Concepedia

Publication | Open Access

Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes

DOIFull Paper Access

177

Citations

15

References

2009

Year

Bernard Zinman, Steven M. Haffner, William H. Herman, Rury R. Holman, John M. Lachin, Barbara G. Kravitz, Gitanjali Paul, Nigel C. Jones, R. Paul Aftring, Giancarlo Viberti,
The Journal of Clinical Endocrinology & Metabolism

Abstract

Commonly measured bone biomarkers suggest that changes in bone resorption may be partly responsible for the increased risk of fracture in women taking thiazolidinediones.

References

YearCitations

Page 1